Table 5.

Correlation analyses for CEC and CDCH with age, BMI, and “metabolism profile” components

Characteristics	Healthy + at CAD risk + CAD (n = 45)				Healthy + CKD G3–G5 (n = 47)
	CEC		CDCH		CEC		CDCH
	r	P	r	P	r	P	r	P
Age, y	−0.22	0.1558	−0.47	0.0010	0.41	0.004	−0.51	0.0002
BMI, kg/m2	−0.18	0.3121	−0.41	0.0139	0.35	0.0266	−0.47	0.0020
Metabolism
Total cholesterol, mg/dl	0.25	0.1028	−0.01	0.9558	0.09	0.5442	−0.16	0.2814
LDL-C, mg/dl	0.06	0.7092	−0.18	0.2244	−0.13	0.4030	−0.20	0.1963
HDL-C, mg/dl	0.10	0.5122	0.61	<0.0001	0.02	0.9056	0.26	0.0854
Non–HDL-C, mg/dl	0.20	0.1870	−0.31	0.0409	0.08	0.5850	−0.29	0.0506
TAG, mg/dl	0.15	0.3299	−0.35	0.0190	0.38	0.0101	−0.26	0.0826

BMI, body mass index; CAD, coronary artery disease; CDCH, capacity to deliver cholesterol to hepatocytes; CED, cholesterol efflux capacity; CKD, chronic kidney disease; HDL-C, high-density lipoprotein–associated cholesterol; LDL-C, low-density lipoprotein–associated cholesterol; TAG, triacylglycerol (triglyceride).

Correlation analysis is presented in terms of Spearman rank-based correlation coefficients r (significance level α = 0.05).